CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shugart, E. C.
Right arrow Articles by Umek, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shugart, E. C.
Right arrow Articles by Umek, R. M.

Cell Growth & Differentiation, Vol 8, Issue 10 1091-1098, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Dexamethasone signaling is required to establish the postmitotic state of adipocyte development

EC Shugart and RM Umek
Department of Biology, University of Virginia, Charlottesville 22903, USA.

The clonal expansion phase of 3T3-L1 adipose conversion is a distinct mitotic period during which the initiation of differentiation occurs concomitant with a discrete set of mitotic divisions. During clonal expansion, a cocktail of adipogenic hormones, including the glucocorticoid dexamethasone, induced 3T3-L1 cells to progress from postconfluent adipoblasts to postmitotic adipocytes. It is reported here that expression of the growth arrest-associated gene 2 (gas2) discriminated reversible, postconfluent growth arrest from irreversible, postmitotic growth arrest. In the absence of dexamethasone, 3T3-L1 cells underwent mitoses but failed to establish postmitotic growth arrest, as evidenced by the persistence of elevated GAS2 mRNA. Moreover, the dexamethasone-deprived 3T3-L1 cells appeared to revert to postconfluent growth arrest, as judged by (a) their ability to reenter logarithmic growth under permissive conditions, and (b) their ability to undergo adipose conversion when subsequently challenged with a complete cocktail of adipogenic hormones. The growth potentiating factor-encoding gene, gas6, was shown to be an immediate-early target of dexamethasone. These findings reveal the requirement for dexamethasone in establishing the postmitotic state that accompanies differentiation. In addition, the results suggest that dexamethasone signaling influences the mitotic divisions of clonal expansion by determining the nature of the growth arrest state assumed upon exit from the cell cycle.


This article has been cited by other articles:


Home page
Am J Clin NutrHome page
T. Dimitriou, C. Maser-Gluth, and T. Remer
Adrenocortical activity in healthy children is associated with fat mass
Am J Clin Nutr, March 1, 2003; 77(3): 731 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. L. Alexander, L. G. Ganem, P. Fernandez-Salguero, F. Gonzalez, and C. R. Jefcoate
Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis
J. Cell Sci., November 1, 1998; 111(22): 3311 - 3322.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.